RxDoctor Payments Data

Jaime King

Optometrist · Rockford, ILNPI 1225131428

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,100 of the $10,396 with a category attached, or 87.5%. 10 manufacturers reported payments, led by Lumenis BE Inc at 49.1% of the total. Reporting peaked in 2022 at $4,567 and has fallen 96.8% since, to $145 in 2025. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,396in general payments, 2019–2025

Across 53 payments — averaging $196.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$5K
  • Lumenis, Inc$4K
  • Coopervision Inc.$1K
  • Shire North American Group Inc$100
  • Optos, Inc.$81
  • Sight Sciences, Inc.$45
  • plus $89 from 4 others

What the payments were for

  • Speaking & faculty fees$9,10088%
  • Food & beverage$1,19612%
  • Gifts$190%
  • Entertainment$360%
  • Other$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,396 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$16,765
Medicare patients
61
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost107$1,300
Brimonidine Tartrate12$1,151
Timolol Maleate27$367

Paid to pharmacies, not to this prescriber.

Other optometrist in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →